BackAcadia Healthcare Company Overview
Acadia Healthcare Company Inc

Acadia Healthcare Company Target Price

See Acadia Healthcare Company's analyst price targets ($37) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$32.25

Average Target Price

$37.1415.2% upside

7 analysts in the last 4 months

High: $40 | Low: $32

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-28Raymond JamesAndrew Cooper$3920.9% upsideOpen
2026-09-23Leerink PartnersWhit Mayo$332.3% upsideOpen
2026-07-30Barclays$320.8% downsideOpen
2026-07-30GuggenheimJason Cassorla$3920.9% upsideOpen
2026-07-20GuggenheimJason Cassorla$3817.8% upsideOpen
2026-07-14KeyBanc$4024% upsideOpen
2026-07-09UBS$3920.9% upsideOpen
2026-06-03JefferiesBrian Tanquilut$307% downsideOpen
2026-05-27KeyBancMatthew Gillmor$307% downsideOpen
2026-05-04Guggenheim$313.9% downsideOpen
2026-05-04RBC Capital$313.9% downsideOpen
2026-05-01Cantor Fitzgerald$307% downsideOpen
2026-04-30Barclays$2522.5% downsideOpen
2026-04-20Jefferies$24.524% downsideOpen
2026-04-17UBS$313.9% downsideOpen
2026-02-26Leerink PartnersWhit Mayo$2231.8% downsideOpen
2026-02-26Raymond JamesJohn Ransom$2522.5% downsideOpen
2026-02-23GuggenheimJason Cassorla$2231.8% downsideOpen
2026-01-22JefferiesBrian Tanquilut$1553.5% downsideOpen
2026-01-14RBC Capital$1747.3% downsideOpen
2025-12-18Mizuho Securities$1747.3% downsideOpen
2025-12-04BarclaysAndrew Mok$1456.6% downsideOpen
2025-12-03Leerink Partners$1456.6% downsideOpen
2025-12-03KeyBancMatthew Gillmor$2522.5% downsideOpen
2025-12-03UBS$2425.6% downsideOpen
2025-12-03Raymond JamesSarah James$1747.3% downsideOpen
2025-12-03Cantor Fitzgerald$1747.3% downsideOpen
2025-12-03RBC Capital$1941.1% downsideOpen
2025-12-03Deutsche BankPito Chickering$2038% downsideOpen
2025-11-07Raymond JamesSarah James$2231.8% downsideOpen
2025-10-08KeyBanc$358.5% upsideOpen
2025-10-03Raymond JamesJohn Ransom$307% downsideOpen
2025-08-13Mizuho SecuritiesAnn Hynes$2231.8% downsideOpen
2025-08-13RBC CapitalBen Hendrix$2813.2% downsideOpen
2025-05-14KeyBancMatthew Gillmor$5570.5% upsideOpen
2025-03-03RBC Capital$4333.3% upsideOpen
2024-10-21Leerink PartnersWhit Mayo$87169.8% upsideOpen
2024-09-27BarclaysAndrew Mok$76135.7% upsideOpen
2024-08-01BarclaysAndrew Mok$83157.4% upsideOpen
2024-05-22RBC CapitalFrank Morgan$94191.5% upsideOpen
2024-05-03Mizuho SecuritiesAnn Hynes$70117.1% upsideOpen
2024-04-25Deutsche BankPito Chickering$70117.1% upsideOpen
2022-12-12RBC Capital$93188.4% upsideOpen
2022-08-26Leerink Partners$103219.4% upsideOpen
2022-08-01RBC Capital$94191.5% upsideOpen
2022-08-01Raymond James$100210.1% upsideOpen
2022-07-29Mizuho Securities$78141.9% upsideOpen
2022-07-29Barclays$85163.6% upsideOpen
2022-07-28UBS$90179.1% upsideOpen
2022-06-20Loop Capital MarketsJoseph France$72123.3% upsideOpen

Acadia Healthcare Company (ACHC) FAQ

The latest target price for ACHC is $37. Investors often review this figure alongside Acadia Healthcare Company's historical trend and sector peers before judging valuation or financial health.

Acadia Healthcare Company trades near $32.25 while the consensus target sits at $37 (15.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ACHC's target price ($37), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Acadia Healthcare Company's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.